SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Earum Pharmaceuticals informs about resignation of CFO

09 Aug 2023 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para A of Part A of Schedule III to the said Regulations, Earum Pharmaceuticals has informed that Payal Patel has resigned from the position of the Chief Financial Officer of the Company with effect from 9th August, 2023. Further, the Company has received confirmation from Payal Patel that there are no other material reasons for her resignation other than those which are provided in the resignation letter. The relevant details in terms of SEBI (LODR) Regulations, 2015 read with SEBI circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 is enclosed as Annexure A.

The above information is a part of company’s filings submitted to BSE.

Murae Organisor Share Price

0.19 0.00 (0.00%)
25-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 224.50
Adani Enterprises 2511.75
Amrapali Industries 18.15
Rashi Peripheral 512.15
PDS 299.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×